Kaskela Law LLC is actively investigating the fairness of the recently announced buyout of Verint (NASDAQ: VRNT) shareholders to determine whether the buyout price undervalues the company's shares. Verint shareholders are strongly encouraged to contact the firm to discuss their legal rights and options with respect to this buyout proposal.

Click here to receive information about your legal rights and options: https://kaskelalaw.com/case/verint/

On August 25, 2025, Verint announced that it had agreed to be acquired by private equity firm Thoma Bravo at a price of $20.50 per share in cash. Following the closing of the transaction, Verint shareholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The investigation so far has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and consideration unfair to the company’s shareholders. Further, at the time the transaction was announced, numerous stock analysts were maintaining price targets in excess of $30.00 per share for Verint’s shares.

Verint shareholders who believe the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (888) 715 – 1740, or by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/verint/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250829142036/en/

The investigation so far has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and consideration unfair to the company’s shareholders.